Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Decreased Medial Prefrontal Cortex Glutamate Levels in Perimenopausal Women

Bibliographic Data

ID15519618
AuthorsSidney Yap (0000-0002-7364-3715, University of Alberta, corresponding author), Jessica Luki (University of Alberta), Christopher C Hanstock (University of Alberta), Peter Seres (0000-0002-8812-2234, University of Alberta), Tami Shandro (Royal Alexandra Hospital), Sarah Hanstock (University of Alberta), Sarah E C Hanstock, Alynna Lirette, Huaying Zhao (0000-0002-8827-6639, University of Alberta), Katherine J Aitchison (0000-0002-1107-3024, Women and Children’s Health Research Institute), Jean‐Michel Le Mellédo (0000-0002-0454-6698, University of Alberta), Jean-Michel Le Melledo
Year2021
Volume12
Pages763562-763562
Publication date2021-12-13
Open AccessYes
TypeARTICLE
VenueFrontiers in Psychiatry (JOURNAL)
Journal identifiersISSN: 1664-0640 • E-ISSN: 1664-0640
PublisherFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2021.763562
PMID34966302
OpenAlexW4200504609
LanguageEN
Citations received1
References cited28

Objective: There is an increased risk of experiencing depression during perimenopause (PM), a period of rapidly changing female hormone concentrations. Women at particular risk of developing major depression (MD) during PM are those with history of mood sensitivity to female hormone fluctuations i.e., women with a history of premenstrual dysphoric disorder (PMDD) and/or post-partum depression (PPD). Depressive symptomology has been associated with fluctuations of glutamate (Glu) levels in the medial prefrontal cortex (MPFC) in MD patients as well as PMDD and PPD patients. The objective of the study was to compare MPFC Glu levels in healthy perimenopausal and reproductive-aged (RD) women. Methods: Medial prefrontal cortex Glu levels in healthy perimenopausal ( n = 15) and healthy RD women ( n = 16) were compared via Magnetic Resonance Spectroscopy (MRS) scan using a 3 Tesla (T) magnet. Absence of depressive symptomology and psychiatric comorbidity was confirmed via semi-structured interview. Participants were scanned during the early follicular phase (FP) of the menstrual cycle (MC). Results: Mean MPFC Glu concentrations were decreased in the PM group compared to RD group (PM mean = 0.57 ± 0.03, RD mean = 0.63 ± 0.06, t = -3.84, df = 23.97, p = 0.001). Conclusion: Perimenopause is associated with decreases in MPFC Glu levels. This decrease may be contributing to the increased risk of experiencing depression during PM. Further research should assess MPFC Glu levels in perimenopausal women suffering from MD

Cognition · Depression (economics · Glutamate receptor · Hormone · Major depressive disorder · Menstrual cycle · Mood · Prefrontal cortex · Premenstrual dysphoric disorder · Psychiatry · Advanced NMR Techniques and Applications · Biochemical effects in animals · Medicine · Neuroscience and Neuropharmacology Research · Psychology · Endocrinology · Internal Medicine · Physiology

  • A comparative magnetic resonance spectroscopy study of Gaba+ and glutamate referenced to creatine and phosphocreatine in the left dorsolateral prefrontal cortex of perimenopausal women and women of reproductive age

    Open Access•Kim Tran, Kim H Tran et al.•Frontiers in Psychiatry•2022

Citations per year0.25
Citation span2022 - 2022 (1)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae